{{Rsnum
|rsid=7715172
|Gene=EGFLAM
|Chromosome=5
|position=38452792
|Orientation=plus
|GMAF=0.09091
|Gene_s=EGFLAM
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 93.8 | 6.2 | 0.0
| YRI | 34.7 | 44.2 | 21.1
| ASW | 40.4 | 47.4 | 12.3
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 99.0 | 1.0 | 0.0
| LWK | 35.5 | 55.5 | 9.1
| MEX | 98.3 | 1.7 | 0.0
| MKK | 44.5 | 41.3 | 14.2
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22760553
  |Trait=Response to citalopram treatment
  |Title=Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
  |RiskAllele=G
  |Pval=3E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}